Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Mar 17, 2021 |
EVP, COO & CCO
|
EVP, COO & CCO | Form 4 | Other acquisition or disposition | -- | -- | 14,139 |
| Mar 17, 2021 |
Director, CEO & President
|
Director, CEO & President | Form 4 | Other acquisition or disposition | -- | -- | 1,538 |
| Mar 16, 2021 |
EVP & Chief Financial Officer
|
EVP & Chief Financial Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 16,318 | $3.69 | 400,451 |
| Mar 16, 2021 |
Chief Medical Officer
|
Chief Medical Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 18,828 | $3.69 | 353,017 |
| Mar 16, 2021 |
Chief Legal Officer
|
Chief Legal Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 16,318 | $3.69 | 316,832 |
| Mar 16, 2021 |
EVP, COO & CCO
|
EVP, COO & CCO | Form 4 | Open market or private sale of non-derivative or derivative security | 18,828 | $3.69 | 412,531 |
| Mar 16, 2021 |
Director, CEO & President
|
Director, CEO & President | Form 4 | Open market or private sale of non-derivative or derivative security | 28,243 | $3.69 | 565,028 |
| Mar 15, 2021 |
EVP & Chief Financial Officer
|
EVP & Chief Financial Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 20,365 | $3.62 | 416,769 |
| Mar 15, 2021 |
Chief Medical Officer
|
Chief Medical Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 22,631 | $3.62 | 371,845 |
| Mar 15, 2021 |
Chief Legal Officer
|
Chief Legal Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 14,362 | $3.62 | 333,150 |
| Mar 15, 2021 |
EVP, COO & CCO
|
EVP, COO & CCO | Form 4 | Open market or private sale of non-derivative or derivative security | 23,291 | $3.62 | 431,359 |
| Mar 15, 2021 |
Director, CEO & President
|
Director, CEO & President | Form 4 | Open market or private sale of non-derivative or derivative security | 40,091 | $3.62 | 593,271 |
| Feb 24, 2021 |
Chief Medical Officer
|
Chief Medical Officer | Form 4 | Other acquisition or disposition | -- | -- | 7,226 |
| Feb 23, 2021 |
EVP & Chief Financial Officer
|
EVP & Chief Financial Officer | Form 4 | Other acquisition or disposition | -- | -- | 11,840 |
| Feb 23, 2021 |
Chief Legal Officer
|
Chief Legal Officer | Form 4 | Other acquisition or disposition | -- | -- | 6,250 |
| Feb 23, 2021 |
EVP, COO & CCO
|
EVP, COO & CCO | Form 4 | Other acquisition or disposition | -- | -- | 14,139 |
| Feb 23, 2021 |
Director, CEO & President
|
Director, CEO & President | Form 4 | Other acquisition or disposition | -- | -- | 1,538 |
| Feb 22, 2021 |
EVP & Chief Financial Officer
|
EVP & Chief Financial Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 4,000 | $3.73 | 437,134 |
| Feb 22, 2021 |
Chief Legal Officer
|
Chief Legal Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 4,000 | $3.73 | 347,512 |
| Feb 22, 2021 |
EVP, COO & CCO
|
EVP, COO & CCO | Form 4 | Open market or private sale of non-derivative or derivative security | 5,000 | $3.73 | 454,650 |
| Feb 22, 2021 |
Director, CEO & President
|
Director, CEO & President | Form 4 | Open market or private sale of non-derivative or derivative security | 7,500 | $3.73 | 633,362 |
| Feb 19, 2021 |
EVP & Chief Financial Officer
|
EVP & Chief Financial Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 4,672 | $3.64 | 441,134 |
| Feb 19, 2021 |
Chief Legal Officer
|
Chief Legal Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 3,295 | $3.64 | 351,512 |
| Feb 19, 2021 |
EVP, COO & CCO
|
EVP, COO & CCO | Form 4 | Open market or private sale of non-derivative or derivative security | 5,018 | $3.64 | 459,650 |
| Feb 19, 2021 |
Director, CEO & President
|
Director, CEO & President | Form 4 | Open market or private sale of non-derivative or derivative security | 7,257 | $3.64 | 640,862 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.